DE2110387C3 - Verfahren zur Herstellung von Cephalosporinverbindungen - Google Patents

Verfahren zur Herstellung von Cephalosporinverbindungen

Info

Publication number
DE2110387C3
DE2110387C3 DE2110387A DE2110387A DE2110387C3 DE 2110387 C3 DE2110387 C3 DE 2110387C3 DE 2110387 A DE2110387 A DE 2110387A DE 2110387 A DE2110387 A DE 2110387A DE 2110387 C3 DE2110387 C3 DE 2110387C3
Authority
DE
Germany
Prior art keywords
acid
carboxylic acid
cephem
ester
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE2110387A
Other languages
German (de)
English (en)
Other versions
DE2110387A1 (de
DE2110387B2 (de
Inventor
Gary Vernon Indianapolis Kaiser
Ian Glaisby Greenwood Wright
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of DE2110387A1 publication Critical patent/DE2110387A1/de
Publication of DE2110387B2 publication Critical patent/DE2110387B2/de
Application granted granted Critical
Publication of DE2110387C3 publication Critical patent/DE2110387C3/de
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/02Preparation
    • C07D501/04Preparation from compounds already containing the ring or condensed ring systems, e.g. by dehydrogenation of the ring, by introduction, elimination or modification of substituents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE2110387A 1970-03-04 1971-03-04 Verfahren zur Herstellung von Cephalosporinverbindungen Expired DE2110387C3 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US1656170A 1970-03-04 1970-03-04

Publications (3)

Publication Number Publication Date
DE2110387A1 DE2110387A1 (de) 1971-09-16
DE2110387B2 DE2110387B2 (de) 1979-04-26
DE2110387C3 true DE2110387C3 (de) 1979-12-13

Family

ID=21777764

Family Applications (1)

Application Number Title Priority Date Filing Date
DE2110387A Expired DE2110387C3 (de) 1970-03-04 1971-03-04 Verfahren zur Herstellung von Cephalosporinverbindungen

Country Status (9)

Country Link
US (1) US3660395A (enExample)
JP (1) JPS55162792A (enExample)
BE (1) BE763689A (enExample)
CH (1) CH585759A5 (enExample)
DE (1) DE2110387C3 (enExample)
ES (1) ES388866A1 (enExample)
FR (1) FR2128096B1 (enExample)
GB (1) GB1300718A (enExample)
NL (1) NL7102928A (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3852282A (en) * 1969-04-01 1974-12-03 Squibb & Sons Inc Certain 2-substituted cephalosporins
US4123612A (en) * 1970-08-10 1978-10-31 Eli Lilly And Company 7-(5-Amino-5-carboxyvaleramido)-3-(carbamoyoloxymethyl)-3-cephem-4-carboxylic acid
CS183696B2 (en) * 1971-02-25 1978-07-31 Robert R Chauvette Method for producing derivatives of 3-methyl-delta up3-cephem-4-carboxylic acid
US3923795A (en) * 1972-06-19 1975-12-02 Lilly Co Eli 2-Alkoxycephalosporins
US4098999A (en) * 1972-10-16 1978-07-04 E. R. Squibb & Sons, Inc. Certain 2-substituted cephalosporins
JPS49116087A (enExample) * 1973-03-14 1974-11-06
US3907785A (en) * 1973-07-17 1975-09-23 Lilly Co Eli Tricyclic cephalosporins
US3933806A (en) * 1973-07-17 1976-01-20 Eli Lilly And Company Cephalosporin michael adducts
US3941779A (en) * 1973-11-12 1976-03-02 E. R. Squibb & Sons, Inc. Method for producing 2-(substituted thio)-3-cephem derivatives
US3968109A (en) * 1973-11-23 1976-07-06 E. R. Squibb & Sons, Inc. Production of 2-(thio substituted)cephalosporin sulfoxides and 2-(thio substituted)cephalosporins
US4049806A (en) * 1975-08-15 1977-09-20 Syntex (U.S.A.) Inc. Cephalosporin type antibacterials
US3983113A (en) * 1975-08-15 1976-09-28 Syntex (U.S.A.) Inc. Cephalosporin type antibacterials
US4145538A (en) * 1976-05-06 1979-03-20 Eli Lilly And Company 3-Carbamyloxymethyl-cephalosporins
US5037975A (en) * 1988-09-16 1991-08-06 Eli Lilly And Company Cephalosporin free radical compounds
US4939249A (en) * 1988-09-16 1990-07-03 Eli Lilly And Company Process for 1-carba(dethia) cephalosporins

Also Published As

Publication number Publication date
DE2110387A1 (de) 1971-09-16
US3660395A (en) 1972-05-02
JPS55162792A (en) 1980-12-18
FR2128096A1 (enExample) 1972-10-20
FR2128096B1 (enExample) 1974-09-06
ES388866A1 (es) 1973-06-01
NL7102928A (enExample) 1971-09-07
GB1300718A (en) 1972-12-20
DE2110387B2 (de) 1979-04-26
CH585759A5 (enExample) 1977-03-15
BE763689A (fr) 1971-09-03

Similar Documents

Publication Publication Date Title
DE2110387C3 (de) Verfahren zur Herstellung von Cephalosporinverbindungen
DE3316798A1 (de) Verfahren zur herstellung von cephemverbindungen
EP0137440A2 (de) Cephalosporinderivate und Verfahren zu ihrer Herstellung
DE2736471C2 (enExample)
DE3005888C2 (enExample)
DE2824004A1 (de) Verfahren zur herstellung einer 7-substituierten-3-cephem-4-carbonsaeure
DE60020869T2 (de) Ein verfahren zur herstellung von hochreinem cefpodoxim-proxetil
DE2534926C2 (de) Verfahren zur Herstellung von Estern der 7-Oxo- und 7β-Hydroxy-cephalosporansäure und deren 3-substituierten Derivaten
DE2534946C2 (de) Verfahren zur Herstellung von 7β-Acylamino-7α-methoxycephalosporinen
DE2223667C2 (de) Verfahren zur Herstellung von 8-Oxo-5-thia-1-azabicyclo-[4,2,0]oct-2-en- oder -3-en-Verbindungen
DE2822876C2 (enExample)
DE1545679A1 (de) Neue Derivate der 7-Amino-cephalosporansaeure
DE2166561A1 (de) 6-aminopenicillansulfoxidsilylester
DE2333256A1 (de) Halogenpenam- und halogencephamderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE2633005A1 (de) Cephem- und penamverbindungen und verfahren zu ihrer herstellung
DE2709505C3 (de) 7-Thienyl- und 7-Furyl-α -methylsulfonyl-acetamido-3- (1-methyl-1H-tetrazol-5-ylthiomethyl)-3-cephem-4-carbonsäuren sowie diese enthaltendes antibakterielles Mittel
DE3534857A1 (de) Cephalosporinsulfoxide, verfahren zu deren herstellung und deren verwendung bei der herstellung von cephalosporinen
DE2559932C2 (de) Cephalosporine, Verfahren zur Herstellung derselben und Mittel mit einem Gehalt derselben
AT403161B (de) Verfahren zur herstellung von cephemverbindungen
DE3782939T2 (de) Kristalline cephalosporinderivate.
DE1906194C3 (de) 3-Brommethyl-A2 -cephalosporine und Verfahren zu ihrer Herstellung
DE2265751C2 (de) 5,8-Dioxo-5-thia-1-azabicyclo[4,2,0]oct-2-en- oder 8-Oxo-5-thia-1-azabicyclo[4,2,0]oct-3-en Verbindungen und deren Weiterverarbeitung
AT368510B (de) Verfahren zur herstellung von neuen 3-phosphonocarbamoyloxymethylcephalosporinverbindungen
AT411598B (de) Verfahren zur herstellung von cephalosporinen
EP0065488A1 (de) Verfahren zur Herstellung von 4-Thio-azetidinon-Verbindungen

Legal Events

Date Code Title Description
C3 Grant after two publication steps (3rd publication)
8328 Change in the person/name/address of the agent
8339 Ceased/non-payment of the annual fee